Gene · 9159
Papers1,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC). | Cancers (Basel) | 2023 | 37370779 | PubTator, text mining | PubMed |
| Potential Diagnostic Biomarker Detection for Prostate Cancer Using Untargeted and Targeted Metabolomic Profiling. | Curr Issues Mol Biol | 2023 | 37367069 | PubTator, text mining | PubMed |
| Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition. | J Clin Immunol | 2023 | 37358695 | PubTator, text mining | PubMed |
| [Comparison of next-generation flow cytometry and next-generation sequencing in the assessment of minimal residual disease in multiple myeloma]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37357003 | PubTator, text mining | PubMed |
| Plasma Soluble Podoplanin as a Biomarker of Hypercoagulability and Cellular Immunity Status in Patients With Non-small Cell Lung Cancer. | Clin Appl Thromb Hemost | 2023 | 37345296 | PubTator, text mining | PubMed |
| Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages. | Cancers (Basel) | 2023 | 37345054 | PubTator, text mining | PubMed |
| Scipion Flexibility Hub: an integrative framework for advanced analysis of conformational heterogeneity in cryoEM. | Acta Crystallogr D Struct Biol | 2023 | 37326585 | PubTator, text mining | PubMed |
| Influence of Umbilical Cord Blood Biochemical Parameters and Disease Condition on the Expression of the TSG-6 Gene in Umbilical Mesenchymal Stem Cells. | Med Sci Monit | 2023 | 37312421 | PubTator, text mining | PubMed |
| MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells. | Oncoimmunology | 2023 | 37304055 | PubTator, text mining | PubMed |
| Dual role of ANGPTL4 in inflammation. | Inflamm Res | 2023 | 37300585 | PubTator, text mining | PubMed |
| Fabrication of CuO-NP-Doped PVDF Composites Based Electrospun Triboelectric Nanogenerators for Wearable and Biomedical Applications. | Polymers (Basel) | 2023 | 37299242 | PubTator, text mining | PubMed |
| Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells. | Cancers (Basel) | 2023 | 37296864 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal changes in cell heterogeneity during progression of human tendinopathy. | BMC Biol | 2023 | 37280595 | PubTator, text mining | PubMed |
| Nontargeted metabolomics analysis of follicular fluid in patients with endometriosis provides a new direction for the study of oocyte quality. | MedComm (2020) | 2023 | 37265938 | PubTator, text mining | PubMed |
| Rhinal and hippocampal event-related potentials as epileptogenic zone markers in the pre-surgical evaluation of temporal epilepsies: a systematic review. | Arq Neuropsiquiatr | 2023 | 37257470 | PubTator, text mining | PubMed |
| Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy. | Nat Commun | 2023 | 37244942 | PubTator, text mining | PubMed |
| Hyperthermia promotes M1 polarization of macrophages via exosome-mediated HSPB8 transfer in triple negative breast cancer. | Discov Oncol | 2023 | 37233869 | PubTator, text mining | PubMed |
| Investigation of heteroscedasticity in polygenic risk scores across 15 quantitative traits. | Front Genet | 2023 | 37229196 | PubTator, text mining | PubMed |
| Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab. | Front Immunol | 2023 | 37215114 | PubTator, text mining | PubMed |
| Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank. | Nat Commun | 2023 | 37208353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9159/papers?page=10